COVID-19 Impact on Global Antiserum Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Antiserum Product Introduction
• 1.2 Market Segments
• 1.3 Key Antiserum Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Antiserum Market Size Growth Rate by Type
  • 1.4.2 Antitoxin Serum
  • 1.4.3 Antibacterial Serum
  • 1.4.4 Antiviral Serum
  • 1.4.5 Anti-Rh Serum
• 1.5 Market by Application
  • 1.5.1 Global Antiserum Market Size Growth Rate by Application
  • 1.5.2 Laboratory
  • 1.5.3 Clinical
  • 1.5.4 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Antiserum Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Antiserum Industry
    • 1.6.1.1 Antiserum Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Antiserum Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Antiserum Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Antiserum Market Size Estimates and Forecasts
  • 2.1.1 Global Antiserum Revenue 2015-2026
  • 2.1.2 Global Antiserum Sales 2015-2026
• 2.2 Antiserum Market Size by Region: 2020 Versus 2026
  • 2.2.1 Global Antiserum Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Antiserum Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Antiserum Competitor Landscape by Players

• 3.1 Antiserum Sales by Manufacturers
  • 3.1.1 Antiserum Sales by Manufacturers (2015-2020)
  • 3.1.2 Antiserum Sales Market Share by Manufacturers (2015-2020)
• 3.2 Antiserum Revenue by Manufacturers
  • 3.2.1 Antiserum Revenue by Manufacturers (2015-2020)
  • 3.2.2 Antiserum Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Antiserum Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2019
  • 3.2.5 Global Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Antiserum Price by Manufacturers
• 3.4 Antiserum Manufacturing Base Distribution, Product Types
  • 3.4.1 Antiserum Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Antiserum Product Type
  • 3.4.3 Date of International Manufacturers Enter into Antiserum Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Antiserum Market Size by Type (2015-2020)
  • 4.1.1 Global Antiserum Sales by Type (2015-2020)
  • 4.1.2 Global Antiserum Revenue by Type (2015-2020)
  • 4.1.3 Antiserum Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Antiserum Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Antiserum Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Antiserum Revenue Forecast by Type (2021-2026)
  • 4.2.3 Antiserum Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Antiserum Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

• 5.1 Global Antiserum Market Size by Application (2015-2020)
  • 5.1.1 Global Antiserum Sales by Application (2015-2020)
  • 5.1.2 Global Antiserum Revenue by Application (2015-2020)
  • 5.1.3 Antiserum Price by Application (2015-2020)
• 5.2 Antiserum Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Antiserum Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Antiserum Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Antiserum Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Antiserum by Country
  • 6.1.1 North America Antiserum Sales by Country
  • 6.1.2 North America Antiserum Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Antiserum Market Facts & Figures by Type
• 6.3 North America Antiserum Market Facts & Figures by Application

7 Europe

• 7.1 Europe Antiserum by Country
  • 7.1.1 Europe Antiserum Sales by Country
  • 7.1.2 Europe Antiserum Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Antiserum Market Facts & Figures by Type
• 7.3 Europe Antiserum Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Antiserum by Region
  • 8.1.1 Asia Pacific Antiserum Sales by Region
  • 8.1.2 Asia Pacific Antiserum Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Antiserum Market Facts & Figures by Type
• 8.3 Asia Pacific Antiserum Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Antiserum by Country
  • 9.1.1 Latin America Antiserum Sales by Country
  • 9.1.2 Latin America Antiserum Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Antiserum Market Facts & Figures by Type
• 9.3 Central & South America Antiserum Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Antiserum by Country
  • 10.1.1 Middle East and Africa Antiserum Sales by Country
  • 10.1.2 Middle East and Africa Antiserum Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Antiserum Market Facts & Figures by Type
• 10.3 Middle East and Africa Antiserum Market Facts & Figures by Application

11 Company Profiles

• 11.1 Charles River
  • 11.1.1 Charles River Corporation Information
  • 11.1.2 Charles River Description, Business Overview and Total Revenue
  • 11.1.3 Charles River Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Charles River Antiserum Products Offered
  • 11.1.5 Charles River Recent Development
• 11.2 SSI Diagnostica
  • 11.2.1 SSI Diagnostica Corporation Information
  • 11.2.2 SSI Diagnostica Description, Business Overview and Total Revenue
  • 11.2.3 SSI Diagnostica Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 SSI Diagnostica Antiserum Products Offered
  • 11.2.5 SSI Diagnostica Recent Development
• 11.3 BD
  • 11.3.1 BD Corporation Information
  • 11.3.2 BD Description, Business Overview and Total Revenue
  • 11.3.3 BD Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 BD Antiserum Products Offered
  • 11.3.5 BD Recent Development
• 11.4 GD Animal Health
  • 11.4.1 GD Animal Health Corporation Information
  • 11.4.2 GD Animal Health Description, Business Overview and Total Revenue
  • 11.4.3 GD Animal Health Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 GD Animal Health Antiserum Products Offered
  • 11.4.5 GD Animal Health Recent Development
• 11.5 Novacyt Group
  • 11.5.1 Novacyt Group Corporation Information
  • 11.5.2 Novacyt Group Description, Business Overview and Total Revenue
  • 11.5.3 Novacyt Group Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Novacyt Group Antiserum Products Offered
  • 11.5.5 Novacyt Group Recent Development
• 11.6 OriGene Technologies
  • 11.6.1 OriGene Technologies Corporation Information
  • 11.6.2 OriGene Technologies Description, Business Overview and Total Revenue
  • 11.6.3 OriGene Technologies Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 OriGene Technologies Antiserum Products Offered
  • 11.6.5 OriGene Technologies Recent Development
• 11.7 Bethyl Laboratories
  • 11.7.1 Bethyl Laboratories Corporation Information
  • 11.7.2 Bethyl Laboratories Description, Business Overview and Total Revenue
  • 11.7.3 Bethyl Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Bethyl Laboratories Antiserum Products Offered
  • 11.7.5 Bethyl Laboratories Recent Development
• 11.8 FUJIFILM Wako Pure Chemical Corporation
  • 11.8.1 FUJIFILM Wako Pure Chemical Corporation Corporation Information
  • 11.8.2 FUJIFILM Wako Pure Chemical Corporation Description, Business Overview and Total Revenue
  • 11.8.3 FUJIFILM Wako Pure Chemical Corporation Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 FUJIFILM Wako Pure Chemical Corporation Antiserum Products Offered
  • 11.8.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
• 11.9 Thermo Scientific
  • 11.9.1 Thermo Scientific Corporation Information
  • 11.9.2 Thermo Scientific Description, Business Overview and Total Revenue
  • 11.9.3 Thermo Scientific Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Thermo Scientific Antiserum Products Offered
  • 11.9.5 Thermo Scientific Recent Development
• 11.10 Bio-Rad
  • 11.10.1 Bio-Rad Corporation Information
  • 11.10.2 Bio-Rad Description, Business Overview and Total Revenue
  • 11.10.3 Bio-Rad Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Bio-Rad Antiserum Products Offered
  • 11.10.5 Bio-Rad Recent Development
• 11.1 Charles River
  • 11.1.1 Charles River Corporation Information
  • 11.1.2 Charles River Description, Business Overview and Total Revenue
  • 11.1.3 Charles River Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Charles River Antiserum Products Offered
  • 11.1.5 Charles River Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Antiserum Market Estimates and Projections by Region
  • 12.1.1 Global Antiserum Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Antiserum Revenue Forecast by Regions 2021-2026
• 12.2 North America Antiserum Market Size Forecast (2021-2026)
  • 12.2.1 North America: Antiserum Sales Forecast (2021-2026)
  • 12.2.2 North America: Antiserum Revenue Forecast (2021-2026)
  • 12.2.3 North America: Antiserum Market Size Forecast by Country (2021-2026)
• 12.3 Europe Antiserum Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Antiserum Sales Forecast (2021-2026)
  • 12.3.2 Europe: Antiserum Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Antiserum Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Antiserum Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Antiserum Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Antiserum Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Antiserum Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Antiserum Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Antiserum Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Antiserum Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Antiserum Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Antiserum Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Antiserum Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Antiserum Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Antiserum Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Antiserum Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Antiserum Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source